Full Text Inquiry
ePub [ahead of print] Inquiry Form:

Thank you for your interest in the full text of this ePub article. The full text of this article is not available as yet. Could you please complete and submit the brief EPub full text inquiry form given below and one of our representatives will contact you shortly with details of the article, it's availability, and price on order.


Article Detail:

Title:
Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents

Abstract:
Back ground: Hispolons are natural products known to possess cytoprotective, antioxidant and anti-cancer activities. We have found recently anti TB activity in these compounds. Efforts were made to optimize the structure with bioisosteric replacement of 1,3-diketo functional group with the corresponding pyrazole and isoxazole moieties.

Objective: The goal of this paper is designing of new hispolon isoxazole and pyrazole and the evaluation of their biological activities.

Methods: The designed compounds were prepared using classical organic synthesis methods. The anti-TB activity was evaluated using the MABA method.

Results: A total of 44 compounds were synthesized (1a- 1v and 2a-2v) and screened for anti TB activity and antibacterial activity. The compounds 1b and 1n showed highest potency with MIC 1.6µg/mL against M. tuberculosis H37Rv.

Conclusion: Bioisosteric replacement of 1,3-diketo functional group in hispolons with pyrazole or isoxazole rings have resulted in potent anti TB molecules. Docking simulations of these compounds on mtFabH enzyme resulted in clear understanding on bioactivity profiles of these compounds. Docking scores are in good agreement with the anti TB activity obtained for these compounds. Computational studies and in vitro screening results are indicating at mtFabH as the probable target for these compounds.

Journal Title: Current Topics in Medicinal Chemistry

Price: $95


Inquiry Form

1 + 19 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.